(Q30333304)

18 June 2017

1 reference

title

HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1292709

10 September 2022

main subject

tuberculosis

0 references

prevention of HIV/AIDS

0 references

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

27 November 2023

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

27 November 2023

author name string

Narain JP

1

1 reference

18 June 2017

Raviglione MC

2

1 reference

18 June 2017

Kochi A

3

1 reference

18 June 2017

language of work or name

1 reference

1 December 1992

1 reference

full work available at URL

18 June 2017

https://api.elsevier.com/content/article/PII:096284799290033G?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

https://api.elsevier.com/content/article/PII:096284799290033G?httpAccept=text/plain

27 November 2023

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Tubercle and lung disease

27 November 2023

published in

1 reference

18 June 2017

volume

73

1 reference

18 June 2017

issue

6

1 reference

18 June 2017

page(s)

311-321

1 reference

The global tuberculosis situation and the new control strategy of the World Health Organization

18 June 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Tuberculosis: a global overview of the situation today

27 November 2023

2

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

The potential impact of AIDS on the tuberculosis situation in developed and developing countries

27 November 2023

4

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Tuberculosis and human immunodeficiency virus infection in developing countries

27 November 2023

5

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment

27 November 2023

7

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

27 November 2023

8

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

A retrospective cohort study of the risk of tuberculosis among women of childbearing age with HIV infection in Zaire

27 November 2023

9

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Tuberculosis morbidity in the United States: final data, 1990

27 November 2023

12

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Association between HTLV-III/LAV infection and tuberculosis in Zaire

27 November 2023

13

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

The association of tuberculosis and HIV infection in Burundi

27 November 2023

15

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

HIV infection in patients with tuberculosis in Kinshasa, Zaire

27 November 2023

17

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Impact of HIV on tuberculosis in Zambia: a cross sectional study

27 November 2023

18

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

HIV seropositivity and tuberculosis in a rural Malawi hospital

27 November 2023

19

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

The influence of human immunodeficiency virus infection on tuberculosis in Kampala, Uganda

27 November 2023

21

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Impact of human immunodeficiency virus type 1 on tuberculosis in rural Haiti

27 November 2023

22

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Risk of tuberculosis in patients with HIV-I and HIV-II infections in Abidjan, Ivory Coast

27 November 2023

27

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Pulmonary diseases in patients infected with the human immunodeficiency virus in Zimbabwe, Central Africa

27 November 2023

32

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Characteristics of the acquired immunodeficiency syndrome (AIDS) in Haiti

27 November 2023

33

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis

27 November 2023

39

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

The chest roentgenogram in pulmonary tuberculosis patients seropositive for human immunodeficiency virus type 1.

27 November 2023

42

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

NOSOCOMIAL EPIDEMIC OF ACTIVE TUBERCULOSIS AMONG HIV-INFECTED PATIENTS

27 November 2023

44

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire

27 November 2023

48

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Impact of human immunodeficiency virus on transmission and severity of tuberculosis

27 November 2023

51

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival

27 November 2023

52

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection

27 November 2023

54

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Disseminated BCG in HIV infection

27 November 2023

57

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Disseminated Mycobacterium bovis infection from BCG vaccination of a patient with acquired immunodeficiency syndrome

27 November 2023

59

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Lymphadenitis associated with BCG vaccination: a report of an outbreak in Harare, Zimbabwe

27 November 2023

60

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

BCG vaccine abscesses are unrelated to HIV infection

27 November 2023

62

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Epidemiology of tuberculosis in the United States

27 November 2023

68

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Chemoprophylaxis in inactive tuberculosis: long-term evaluation of a Canadian trial

27 November 2023

71

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide

27 November 2023

74

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Clinical care as part of integrated AIDS management in a Zambian rural community

27 November 2023

76

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Epidemic tuberculosis in a nursing home: a retrospective cohort study

27 November 2023

81

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

The booster phenomenon in serial tuberculin testing

27 November 2023

82

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

Isoniazid as preventive therapy in HIV-infected intravenous drug abusers. A decision analysis

27 November 2023

83

1 reference

https://api.crossref.org/works/10.1016/0962-8479(92)90033-G

27 November 2023

Identifiers

1 reference

18 June 2017

1 reference